MATTHEW H MARTIN
Architects in Arlington, MA
License number
Massachusetts 20298
Issued Date
Aug 16, 2005
Expiration Date
Aug 31, 2017
Type
Architect
Address
Address
Arlington, MA 02474
Professional information
Staff Accountant Ii At Demandware
Position:
Staff Accountant II at Demandware
Location:
Greater Boston Area
Industry:
Accounting
Work:
Demandware
- Burlington, MA since Sep 2012
-
Staff Accountant II
SeraCare Life Sciences
- Milford, MA Jun 2011 - Sep 2012
-
Staff Accountant
Plumley Village, Worcester, MA
Feb 2011 - May 2011
-
Tax Associate Volunteer
Hardy Elementary School
- Arlington, MA Jun 2010 - Jan 2011
-
Day Camp Counselor
Whole Foods Market
- Woburn, MA May 2009 - Aug 2009
-
Meat/Seafood Department Clerk
Home Sweet Home Builders, LLC
- Arlington, MA Jul 2007 - Aug 2009
-
Contractor's Assistant, Snow Removal Foreman
Conneely Contracting, Inc
- Arlington, MA Jun 2006 - Jul 2008
-
Laborer, Contactor's Assistant
Education:
Assumption College 2007 - 2011
Bachelor of Arts (BA), Accounting
Bachelor of Arts (BA), Accounting
Aryl Nitrogen-Containing Bicyclic Compounds And Methods Of Use
US Patent:
2007005, Mar 8, 2007
Filed:
Sep 30, 2005
Appl. No.:
11/240590
Inventors:
Vinod Patel - Acton MA, US
Joseph Kim - Wayland MA, US
Stephanie Geuns-Meyer - Medford MA, US
Stuart Chaffee - Cambridge MA, US
Victor Cee - Mansfield MA, US
Brian Hodous - Cambridge MA, US
Steven Bellon - Wellesley MA, US
Jean-Christophe Harmange - Andover MA, US
Philip Olivieri - Medford MA, US
Maya Thaman - Ventura CA, US
Erin DiMauro - Cambridge MA, US
John Buchanan - Newton MA, US
David McGowan - Pierre, BE
Brian Albrecht - Cambridge MA, US
Holly Deak - Brookline MA, US
Jean Bemis - Arlington MA, US
Ryan White - Somerville MA, US
Matthew Martin - Arlington MA, US
Gregory Habgood - Merrimac MA, US
Paul Tempest - Brookline MA, US
Craig Masse - Cambridge MA, US
William Buckner - Arlington MA, US
Bradley Herberich - Newbury Park CA, US
Russell Graceffa - Hampton NH, US
Dawei Zhang - Thousand Oaks CA, US
Shimin Xu - Santa Barbara CA, US
Kelvin Sham - Thousand Oaks CA, US
Robert Rzasa - Ventura CA, US
James Falsey - Moorpark CA, US
Partha Chakrabarti - Simi Valley CA, US
Guo-Qiang Cao - Thousand Oaks CA, US
Susan Tomlinson - Boston MA, US
Liping Pettus - Thousand Oaks CA, US
Adrian Smith - Simi Valley CA, US
Nick Paras - Santa Monica CA, US
Gang Liu - Oak Park CA, US
Frenel DeMorin - Thousand Oaks CA, US
Andrew Tasker - Simi Valley CA, US
Anthony Reed - Oxnard CA, US
Joseph Kim - Wayland MA, US
Stephanie Geuns-Meyer - Medford MA, US
Stuart Chaffee - Cambridge MA, US
Victor Cee - Mansfield MA, US
Brian Hodous - Cambridge MA, US
Steven Bellon - Wellesley MA, US
Jean-Christophe Harmange - Andover MA, US
Philip Olivieri - Medford MA, US
Maya Thaman - Ventura CA, US
Erin DiMauro - Cambridge MA, US
John Buchanan - Newton MA, US
David McGowan - Pierre, BE
Brian Albrecht - Cambridge MA, US
Holly Deak - Brookline MA, US
Jean Bemis - Arlington MA, US
Ryan White - Somerville MA, US
Matthew Martin - Arlington MA, US
Gregory Habgood - Merrimac MA, US
Paul Tempest - Brookline MA, US
Craig Masse - Cambridge MA, US
William Buckner - Arlington MA, US
Bradley Herberich - Newbury Park CA, US
Russell Graceffa - Hampton NH, US
Dawei Zhang - Thousand Oaks CA, US
Shimin Xu - Santa Barbara CA, US
Kelvin Sham - Thousand Oaks CA, US
Robert Rzasa - Ventura CA, US
James Falsey - Moorpark CA, US
Partha Chakrabarti - Simi Valley CA, US
Guo-Qiang Cao - Thousand Oaks CA, US
Susan Tomlinson - Boston MA, US
Liping Pettus - Thousand Oaks CA, US
Adrian Smith - Simi Valley CA, US
Nick Paras - Santa Monica CA, US
Gang Liu - Oak Park CA, US
Frenel DeMorin - Thousand Oaks CA, US
Andrew Tasker - Simi Valley CA, US
Anthony Reed - Oxnard CA, US
International Classification:
A61K 31/525, A61K 31/519, A61K 31/517
US Classification:
514251000, 514266100, 514264100, 544279000, 544284000, 544257000
Abstract:
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I
wherein A, A, A, B, R, R, Rand Rare defined herein. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of kinase mediated diseases using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention.
Heteroaryl-Substituted Alkyne Compounds And Method Of Use
US Patent:
7776869, Aug 17, 2010
Filed:
Oct 14, 2005
Appl. No.:
11/251490
Inventors:
Stuart C. Chaffee - Cambridge MA, US
Brian K. Albrecht - Cambridge MA, US
Brian L. Hodous - Cambridge MA, US
Matthew W. Martin - Arlington MA, US
David C. McGowan - Woluwe Street Pierre, BE
Erin F. DiMauro - Cambridge MA, US
Gade Reddy - Newbury Park CA, US
Victor J. Cee - Mansfield MA, US
Philip R. Olivieri - Medford MA, US
Anthony Reed - Oxnard CA, US
Karina Romero - Cambridge MA, US
Brian K. Albrecht - Cambridge MA, US
Brian L. Hodous - Cambridge MA, US
Matthew W. Martin - Arlington MA, US
David C. McGowan - Woluwe Street Pierre, BE
Erin F. DiMauro - Cambridge MA, US
Gade Reddy - Newbury Park CA, US
Victor J. Cee - Mansfield MA, US
Philip R. Olivieri - Medford MA, US
Anthony Reed - Oxnard CA, US
Karina Romero - Cambridge MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 239/38, C07D 239/42, A61K 31/505, A61K 31/506, A61P 35/00
US Classification:
514269, 514275, 544299, 544309, 544317, 544320, 544321, 544323, 544324
Abstract:
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I.
Benzomorpholine Derivatives And Methods Of Use
US Patent:
7795254, Sep 14, 2010
Filed:
Oct 28, 2008
Appl. No.:
12/290223
Inventors:
Jean-Christophe Harmange - Andover MA, US
Matthew W. Martin - Arlington MA, US
Yohannes Teffera - Topsfield MA, US
Raju Subramanian - Thousand Oaks CA, US
Ryan White - Somerville MA, US
Roger Zanon - Minneapolis MN, US
Jay Larrow - Wakefield MA, US
Joseph F. Payack - Somerset NJ, US
Mina Dilmeghani Seran - Ankara, TR
Matthew W. Martin - Arlington MA, US
Yohannes Teffera - Topsfield MA, US
Raju Subramanian - Thousand Oaks CA, US
Ryan White - Somerville MA, US
Roger Zanon - Minneapolis MN, US
Jay Larrow - Wakefield MA, US
Joseph F. Payack - Somerset NJ, US
Mina Dilmeghani Seran - Ankara, TR
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 413/12, A61K 31/538
US Classification:
5142305, 544105
Abstract:
Selected benzomorpholine compounds, including 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-(5 -methyl-3-isoxazolyl)-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide, are effective for prophylaxis and treatment of diseases, such as VEGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Aurora Kinase Modulators And Methods Of Use
US Patent:
2011030, Dec 8, 2011
Filed:
Aug 4, 2009
Appl. No.:
13/057144
Inventors:
Holly L. Deak - Brookline MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Jason Brooks Human - Boston MA, US
Matthew W. Martin - Arlington MA, US
Isaac Marx - Somerville MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Jason Brooks Human - Boston MA, US
Matthew W. Martin - Arlington MA, US
Isaac Marx - Somerville MA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
A61K 31/5377, C07D 403/12, C07D 413/14, A61P 35/02, A61K 31/502, A61K 31/513, A61P 35/00, C07D 401/12, C07D 403/14
US Classification:
5142345, 544237, 544119, 514248
Abstract:
The present invention relates to chemical compounds having a general formula Iwherein A, L, R, Rand n are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of such kinase proteins. For example, the compounds are capable of modulating Aurora kinase thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds and methods of treating disease states related to the activity of Aurora kinase.
Compounds And Methods Of Use
US Patent:
8178557, May 15, 2012
Filed:
Jun 9, 2008
Appl. No.:
12/157303
Inventors:
Michele Potashman - Cambridge MA, US
Steven Bellon - Wellesley MA, US
Shon Booker - Thousand Oaks CA, US
Yuan Cheng - Newbury Park CA, US
Joseph L. Kim - Wayland MA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - San Diego CA, US
Jean-Christophe Harmange - Andover MA, US
George Borg - Somerville MA, US
Matthew Weiss - Boston MA, US
Brian L. Hodous - Cambridge MA, US
Russell Graceffa - Hampton NH, US
William H. Buckner - Kittery ME, US
Craig E. Masse - Cambridge MA, US
Deborah Choquette - Medford MA, US
Matthew W. Martin - Arlington MA, US
Julie Germain - Quebec, CA
Lucian V. DiPietro - Gloucester MA, US
Stuart C. Chaffee - Boston MA, US
Joseph J. Nunes - Andover MA, US
John L. Buchanan - Newton MA, US
David C. McGowan - Brussels, BE
Douglas A. Whittington - Waltham MA, US
Gregory J. Habgood - Merrimac MA, US
Vinod F. Patel - Acton MA, US
Daniel La - Brookline MA, US
Steven Bellon - Wellesley MA, US
Shon Booker - Thousand Oaks CA, US
Yuan Cheng - Newbury Park CA, US
Joseph L. Kim - Wayland MA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - San Diego CA, US
Jean-Christophe Harmange - Andover MA, US
George Borg - Somerville MA, US
Matthew Weiss - Boston MA, US
Brian L. Hodous - Cambridge MA, US
Russell Graceffa - Hampton NH, US
William H. Buckner - Kittery ME, US
Craig E. Masse - Cambridge MA, US
Deborah Choquette - Medford MA, US
Matthew W. Martin - Arlington MA, US
Julie Germain - Quebec, CA
Lucian V. DiPietro - Gloucester MA, US
Stuart C. Chaffee - Boston MA, US
Joseph J. Nunes - Andover MA, US
John L. Buchanan - Newton MA, US
David C. McGowan - Brussels, BE
Douglas A. Whittington - Waltham MA, US
Gregory J. Habgood - Merrimac MA, US
Vinod F. Patel - Acton MA, US
Daniel La - Brookline MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/04
US Classification:
514312
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Bis-Aryl Amide Compounds And Methods Of Use
US Patent:
8492404, Jul 23, 2013
Filed:
May 26, 2010
Appl. No.:
12/788201
Inventors:
Matthew W. Martin - Arlington MA, US
David C. McGowan - Brussels, BE
David C. McGowan - Brussels, BE
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A01N 43/42, A61K 31/47, C07D 215/46
US Classification:
514313, 546162
Abstract:
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including autoimmune disease and inflammation. In one embodiment, the compounds have a general Formula I.